Question 1

What is the catalog number for Anti-CD317/BST2 (XmAb 5592) Biosimilar (Monoclonal, IgG)?

Accepted Answer

The catalog number for Anti-CD317/BST2 (XmAb 5592) Biosimilar (Monoclonal, IgG) is A135759.

Question 2

What sizes are available for Anti-CD317/BST2 (XmAb 5592) Biosimilar (Monoclonal, IgG)?

Accepted Answer

Anti-CD317/BST2 (XmAb 5592) Biosimilar (Monoclonal, IgG) is available in the following size(s): 100 µL.

Question 3

Is Anti-CD317/BST2 (XmAb 5592) Biosimilar (Monoclonal, IgG) in stock?

Accepted Answer

Anti-CD317/BST2 (XmAb 5592) Biosimilar (Monoclonal, IgG) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

Question 5

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 6

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Anti-CD317/BST2 (XmAb 5592) Biosimilar (Monoclonal, IgG)

Product Specifications

UniProt

Reactivity

Target

Clonality

Source

Applications

Isotype

Frequently Asked Questions

Explore Other Products

CD86 (BU63), CF647 conjugate, 0.1mg/mL

CD44 Standard (156-3C11), CF740 conjugate, 0.1mg/mL

CD3e (RIV9), CF568 conjugate, 0.1mg/mL

GCDFP-15 (Gross Cystic Disease Fluid Protein 15) (Breast Marker) (PIP/1571), CF488A conjugate, 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF647 conjugate, 0.1mg/mL

CD45RA (111-1C5), CF640R conjugate, 0.1mg/mL